938467-11-9

Basic information

• Product Name: N-(3,3-diphenylpropyl)-2-thiomorpholin-4-ylacetamide
• Synonyms: N-(3,3-diphenylpropyl)-2-thiomorpholin-4-ylacetamide
• CAS NO: 938467-11-9
• Molecular Weight: 354.516
• Mol File: 938467-11-9.mol
• Article Data: 1

Chemical Properties

• CAS DataBase Reference: N-(3,3-diphenylpropyl)-2-thiomorpholin-4-ylacetamide(CAS DataBase Reference)
• NIST Chemistry Reference: N-(3,3-diphenylpropyl)-2-thiomorpholin-4-ylacetamide(938467-11-9)
• EPA Substance Registry System: N-(3,3-diphenylpropyl)-2-thiomorpholin-4-ylacetamide(938467-11-9)

Safety Data

• Hazardous Substances Data: 938467-11-9(Hazardous Substances Data)

Upstream product

• 5586-73-2 3-diphenylpropyl amine 
• 123-90-0 Thiomorpholin 
• 137075-21-9 methyl chloride 

Relevant articles and documents

UREA DERIVATIVES USEFUL AS CALCIUM RECEPTOR MODULATORS

The present invention provides compounds of formula (I): in which Y is oxygen or sulphur; R1 and R”1 are optionally substituted aryl, heteroaryl or a fused ring structure, R2and R'2 are each H, or optionally substituted alkyl, alkylaminoalkyl or dialkylaminoalkyl, or R2 and R'2 and their N form a saturated or unsaturated optionally substituted heterocycle, R3 represents a group of formula -(CH2)P-Ar-Rn, wherein p is 0 or 1 and, when p is 1, is optionally substituted, Ar is aryl or heteroaryl, and each R is H, halogen; hydroxyl; trifiuoromethyl; linear and branched alkyl, alkenyl, alkynyl, and alkoxyl groups, all optionally further substituted by one or more of hydroxy groups, halogen atoms, alkoxy groups, amino groups, and alkylthio groups; linear and branched alkoxyl groups; linear and branched thioalkyl groups; aryl groups; aralkyl groups; aralkoxy groups; aryloxy groups; perfluoroalkyl; -CN; -NR4R5, -C(=X)NR4R5,-O-C(=X)NR4R5, -SO2NR4R5, - Alk-NR4R5, -NZC(=X)(NH)qR6, -Alk-NZC(=X)(NH)qR6, -C(=X)R6, -Alk-C(=X)(NH)qR6, -NHSO2R7, -SO2R7, -SOR7, -SR7, or is a saturated or unsaturated heterocyclyl group, and salts and esters thereof, are useful in the treatment of conditions susceptible to modulating ion channels, to a process for their preparation, their application by way of medicaments, and to pharmaceutical compositions containing them.